Identification of a novel antileishmanial compound through combined in vitro and in silico approaches (2025)
- Authors:
- USP affiliated authors: DUARTE, SIMONE MICHELAN - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; AFONSO, MAYNARA - IFSC ; COSTA, ANALU ROCHA - IFSC ; SILVA, JOÃO VICTOR DA SILVA E - IFSC ; CHELUCCI, RAFAEL CONSOLIN - IFSC ; DÖRING, THIAGO HENRIQUE - IFSC
- Unidade: IFSC
- Subjects: DOENÇAS NEGLIGENCIADAS; ANTIPARASITÁRIOS; PLANEJAMENTO DE FÁRMACOS
- Keywords: Visceral leishmaniasis; Drug discovery; Pharmacokinetics
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Química - SBQ
- Publisher place: São Paulo
- Date published: 2025
- Source:
- Título: Anais
- Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ
-
ABNT
AFONSO, Maynara et al. Identification of a novel antileishmanial compound through combined in vitro and in silico approaches. 2025, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2025. Disponível em: https://repositorio.usp.br/directbitstream/3d9b2aa3-ff6f-424c-b97d-4b1f3267ebe8/3259733.pdf. Acesso em: 29 dez. 2025. -
APA
Afonso, M., Costa, A. R., Silva-Silva, J. V., Duarte, S. M., Chelucci, R. C., Döring, T. H., et al. (2025). Identification of a novel antileishmanial compound through combined in vitro and in silico approaches. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://repositorio.usp.br/directbitstream/3d9b2aa3-ff6f-424c-b97d-4b1f3267ebe8/3259733.pdf -
NLM
Afonso M, Costa AR, Silva-Silva JV, Duarte SM, Chelucci RC, Döring TH, Ferreira LLG, Andricopulo AD. Identification of a novel antileishmanial compound through combined in vitro and in silico approaches [Internet]. Anais. 2025 ;[citado 2025 dez. 29 ] Available from: https://repositorio.usp.br/directbitstream/3d9b2aa3-ff6f-424c-b97d-4b1f3267ebe8/3259733.pdf -
Vancouver
Afonso M, Costa AR, Silva-Silva JV, Duarte SM, Chelucci RC, Döring TH, Ferreira LLG, Andricopulo AD. Identification of a novel antileishmanial compound through combined in vitro and in silico approaches [Internet]. Anais. 2025 ;[citado 2025 dez. 29 ] Available from: https://repositorio.usp.br/directbitstream/3d9b2aa3-ff6f-424c-b97d-4b1f3267ebe8/3259733.pdf - Avaliação biológica e in silico de candidatos a novos fármacos para doenças de chagas
- Avaliação e planejamento de novos candidatos à fármacos para a leishmaniose visceral e doença de chagas
- Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
- Leishmanicidal benzodiazepines as DHFR-TS inhibitors: in vitro and in silico analysis
- Phenotypic screening of H1-antihistamines identifies promethazine and rupatadine as active compounds against Toxocara canis infective larvae
- Discovery of arylpiperazines with broad-spectrum antimicrobial activity and favorable pharmacokinetic profiles
- Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
- Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum
- Aflavinine alkaloids from Aspergillus sp.: antibacterial activity and inosine 5’-monophosphate dehydrogenase (IMPDH) as a potential target in bacillus subtilis
- Assessment of 1,2,3-triazole-selenide hybrids as potential trypanothione reductase inhibitors: implications for trypanocidal activity
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3259733.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
